A phase II trial of weekly 1-hour paclitaxel as second-line therapy for endometrial and cervical cancer

Background The efficacy of weekly paclitaxel has not been well characterized in either cervical or endometrial cancer. Methods Eligible women had disseminated endometrial or squamous cell cancer of the cervix, one prior chemotherapy regimen, measurable disease, and a Gynecologic Oncology Group (GOG)...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of clinical oncology 2008-02, Vol.13 (1), p.62-65
Hauptverfasser:	Homesley, Howard D., Meltzer, Nathan P., Nieves, Lucybeth, Vaccarello, Luis, Lowendowski, George S., Elbendary, Al A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents, Phytogenic - administration & dosage Cancer Research Carcinoma, Squamous Cell - drug therapy Drug Administration Schedule Endometrial Neoplasms - drug therapy Female Humans Infusions, Intravenous Medicine Medicine & Public Health Oncology Original Article Paclitaxel - administration & dosage Surgical Oncology Uterine Cervical Neoplasms - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!